Delivery of siRNA and other macromolecules into skin and cells using a peptide enhancer

Proceedings of the National Academy of Sciences of the United States of America

Volumn 108, Issue 38, 2011, Pages 15816-15821

  Hsu, Tracy ^a   Mitragotri, Samir ^a  

^a University of California   (United States)

Author keywords

Cell penetrating peptide; Dermatology; Drug delivery; Topical; Transdermal

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; INTERLEUKIN 10; PEPTIDE; SKIN PENETRATING AND CELL ENTERING PEPTIDE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; DERMIS; DRUG ABSORPTION; DRUG PENETRATION; DRUG TARGETING; ENDOTHELIUM CELL; EPIDERMIS; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; MACROMOLECULE; MOUSE; NONHUMAN; PINOCYTOSIS; PRIORITY JOURNAL; STRATUM CORNEUM;

ADMINISTRATION, CUTANEOUS; ANIMALS; CELL LINE, TUMOR; CELLS, CULTURED; DRUG DELIVERY SYSTEMS; FEMALE; FLUORESCENT DYES; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (PHOSPHORYLATING); HUMANS; INTERLEUKIN-10; MACROMOLECULAR SUBSTANCES; MICE; MICE, INBRED BALB C; MICROSCOPY, CONFOCAL; PEPTIDE LIBRARY; PEPTIDES; RNA INTERFERENCE; RNA, SMALL INTERFERING; SKIN; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SWINE;

EID: 80053156423     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1016152108     Document Type: Article

References (34)

1. Nichols K, Cook-Bolden F (2009) Allergic skin disease: Major highlights and recent advances. Med Clin North Am 93:1211-1224.
2. Koh H, Geller A (1995) Melanoma control in the United States: Current status. Recent Results Cancer Res 139:215-224.
3. Fleischer AJ, Feldman S, Rapp S (2000) Introduction. The magnitude of skin disease in the United States. Dermatol Clin 18:15-21.
4. Geusens B, Sanders N, Prow T, Van Gele M, Lambert J (2009) Cutaneous short-interfering RNA therapy. Expert Opin Drug Delivery 6:1333-1349.
5. Prausnitz MR, Langer R (2008) Transdermal drug delivery. Nat Biotechnol 26:1261-1268.
6. Guy R (2010) Transdermal drug delivery. Handb Exp Pharmacol (Marcel Dekker, Inc., New York), 2nd Ed., pp 399-410.
7. Kigasawa K, et al. (2010) Noninvasive delivery of siRNA into the epidermis by iontophoresis using an atopic dermatitis-like model rat. Int J Pharm 383:157-160.
8. Ritprajak P, Hashiguchi M, Azuma M (2008) Topical application of cream-emulsified CD86 siRNA ameliorates allergic skin disease by targeting cutaneous dendritic cells. Mol Ther 16:1323-1330. (Pubitemid 351866065)
9. Mitragotri S, Blankschtein D, Langer R (1995) Ultrasound-mediated transdermal protein delivery. Science 269:850-853.
10. Guy RH (1998) Iontophoresis - recent developments. J Pharm Pharmacol 50:371-374.
11. Prausnitz MR (2004) Microneedles for transdermal drug delivery. Adv Drug Delivery Rev 56:581-587.
12. Karande P, Jain A, Mitragotri S (2004) Discovery of transdermal penetration enhancers by high-throughput screening. Nat Biotechnol 22:192-197. (Pubitemid 38160534)
13. Rothbard J, et al. (2000) Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation. Nat Med 6:1253-1257.
14. Lopes L, et al. (2005) Comparative study of the skin penetration of protein transduction domains and a conjugated peptide. Pharm Res 22:750-757. (Pubitemid 40768587)
15. Sawant R, Torchilin V (2010) Intracellular transduction using cell-penetrating peptides. Mol BioSyst 6:628-640.
16. Kim Y, Ludovice P, Prausnitz M (2007) Transdermal delivery enhanced by magainin pore-forming peptide. J Controlled Release 122:375-383. (Pubitemid 47404674)
17. Chen Y, et al. (2006) Transdermal protein delivery by a coadministered peptide identified via phage display. Nat Biotechnol 24:455-460.
18. Karande P, Jain A, Ergun K, Kispersky V, Mitragotri S (2005) Design principles of chemical penetration enhancers for transdermal drug delivery. Proc Natl Acad Sci USA 102:4688-4693. (Pubitemid 40471515)
19. Nakase I, et al. (2004) Cellular uptake of arginine-rich peptides: Roles for macropinocytosis and actin rearrangement. Mol Ther 10:1011-1022. (Pubitemid 39625245)
20. Patel LN, Zaro JL, Shen WC (2007) Cell penetrating peptides: Intracellular pathways and pharmaceutical perspectives. Pharm Res 24:1977-1992. (Pubitemid 47493563)
21. Tamaru M, Akita H, Fujiwara T, Kajimoto K, Harashima H (2010) Leptin-derived peptide, a targeting ligand for mouse brain-derived endothelial cells via macropinocytosis. Biochem Biophys Res Commun 394:587-592.
22. Walsh M, et al. (2006) Evaluation of cellular uptake and gene transfer efficiency of pegylated poly-L-lysine compacted DNA: Implications for cancer gene therapy. Mol Pharm 3:644-653. (Pubitemid 46087481)
23. Potts RO, Guy RH (1992) Predicting skin permeability. Pharm Res 9:663-669.
24. Magnusson B, Pugh W, Roberts M (2004) Simple rules defining the potential of compounds for transdermal delivery or toxicity. Pharm Res 21:1047-1054. (Pubitemid 38870156)
25. Mitragotri S (2003) Modeling skin permeability to hydrophilic and hydrophobic solutes based on four permeation pathways. J Controlled Release 86:69-92.
26. Tang H, Mitragotri S, Blankschtein D, Langer R (2001) Theoretical description of transdermal transport of hydrophilic permeants: Application to low-frequency sonophoresis. J Pharm Sci 90:545-568. (Pubitemid 32378377)
27. Peck KD, Ghanem AH, Higuchi WI (1994) Hindered diffusion of polar molecules through and effective pore radii estimates of intact and ethanol treated human epidermal membrane. Pharm Res 11:1306-1314. (Pubitemid 24287411)
28. Otto M (2009) Staphylococcus epidermidis - the accidental pathogen. Nat Rev Microbiol 7:555-567.
29. Birkenfeld P, Haratz N, Klein G, Sulitzeanu D (1990) Cross-reactivity between the EBNA-1 p107 peptide, collagen, and keratin: Implications for the pathogenesis of rheumatoid arthritis. Clin Immunol Immunopathol 54:14-25. (Pubitemid 20024665)
30. Kang SK, et al. (2008) Identification of a peptide sequence that improves transport of macromolecules across the intestinal mucosal barrier targeting goblet cells. J Biotechnol 135:210-216.
31. Morris CJ, Smith MW, Griffiths PC, McKeown NB, Gumbleton M (2011) Enhanced pulmonary absorption of a macromolecule through coupling to a sequence-specific phage display-derived peptide. J Controlled Release 151:83-94.
32. Leung DY (1995) Atopic dermatitis: The skin as a window into the pathogenesis of chronic allergic diseases. J Allergy Clin Immunol 96:302-318.
33. Palmer CN, et al. (2006) Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38:441-446.
34. Howell MD, et al. (2009) Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol 124((Suppl 2)):R7-R12.